ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ENvue Medical's profit margin for the twelve months ending Jun 30, 2026 was -1093.6%. For fiscal 2025 it was -712.3%, against -144.8% the year before. The highest annual figure on record is -144.8% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -712.3% | −567.5 |
| FY2024 | Dec 31, 2024 | -144.8% | +17.7 |
| FY2023 | Dec 31, 2023 | -162.5% | +561.9 |
| FY2022 | Dec 31, 2022 | -724.5% | +118.1 |
| FY2021 | Dec 31, 2021 | -842.6% | −148.2 |
| FY2020 | Dec 31, 2020 | -694.4% | +398.8 |
| FY2019 | Dec 31, 2019 | -1093.2% | +213.1 |
| FY2018 | Dec 31, 2018 | -1306.3% | +771.1 |
| FY2017 | Dec 31, 2017 | -2077.4% | −841.2 |
| FY2016 | Dec 31, 2016 | -1236.2% | +725.7 |
| FY2015 | Dec 31, 2015 | -1961.9% | −658.0 |
| FY2014 | Dec 31, 2014 | -1303.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2049.8% | −1245.9 |
| Q1 FY2026 | Mar 31, 2026 | -585.3% | −402.7 |
| Q4 FY2025 | Dec 31, 2025 | -4119.2% | −3796.9 |
| Q3 FY2025 | Sep 30, 2025 | 70.6% | +336.1 |
| Q2 FY2025 | Jun 30, 2025 | -803.8% | −719.6 |
| Q1 FY2025 | Mar 31, 2025 | -182.6% | −118.8 |
| Q4 FY2024 | Dec 31, 2024 | -322.3% | −253.2 |
| Q3 FY2024 | Sep 30, 2024 | -265.4% | −106.7 |
| Q2 FY2024 | Jun 30, 2024 | -84.2% | +281.1 |
| Q1 FY2024 | Mar 31, 2024 | -63.8% | +246.0 |
| Q4 FY2023 | Dec 31, 2023 | -69.1% | +915.5 |
| Q3 FY2023 | Sep 30, 2023 | -158.7% | +109.7 |
| Q2 FY2023 | Jun 30, 2023 | -365.3% | +50.9 |
| Q1 FY2023 | Mar 31, 2023 | -309.9% | +9.3 |
| Q3 FY2022 | Sep 30, 2022 | -984.5% | +353.1 |
| Q2 FY2022 | Jun 30, 2022 | -268.5% | −200.5 |
| Q1 FY2022 | Mar 31, 2022 | -416.2% | +4357.6 |
| Q4 FY2021 | Dec 31, 2021 | -319.2% | +798.6 |
| Q3 FY2021 | Sep 30, 2021 | -1337.7% | −723.0 |
| Q2 FY2021 | Jun 30, 2021 | -67.9% | +481.1 |
| Q1 FY2021 | Mar 31, 2021 | -4773.8% | −3965.9 |
| Q4 FY2020 | Dec 31, 2020 | -1117.8% | +253.5 |
| Q3 FY2020 | Sep 30, 2020 | -614.7% | +192.3 |
| Q2 FY2020 | Jun 30, 2020 | -549.1% | −128.2 |
| Q1 FY2020 | Mar 31, 2020 | -807.9% | +2583.2 |
| Q4 FY2019 | Dec 31, 2019 | -1371.3% | +845.4 |
| Q3 FY2019 | Sep 30, 2019 | -806.9% | +1682.0 |
| Q2 FY2019 | Jun 30, 2019 | -420.9% | +203.3 |
| Q1 FY2019 | Mar 31, 2019 | -3391.1% | −2366.5 |
| Q4 FY2018 | Dec 31, 2018 | -2216.7% | +127.6 |
| Q3 FY2018 | Sep 30, 2018 | -2488.9% | −28.9 |
| Q2 FY2018 | Jun 30, 2018 | -624.2% | +1008.4 |
| Q1 FY2018 | Mar 31, 2018 | -1024.7% | +661.9 |
| Q4 FY2017 | Dec 31, 2017 | -2344.3% | −1360.4 |
| Q3 FY2017 | Sep 30, 2017 | -2460.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -1632.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -1686.5% | – |
| Q2 FY2016 | Jun 30, 2016 | -983.9% | – |
See a number that looks wrong?